Prognostic value of PD-L1 overexpression for pancreatic cancer: evidence from a meta-analysis.

Zhuan-Sun, Yongxun; Huang, Fengting; Feng, Min; Zhao, Xinbao; Chen, Wenying; Zhu, Zhe; Zhang, Shineng

Zhuan-Sun, Yongxun; Huang, Fengting; Feng, Min; Zhao, Xinbao; Chen, Wenying; Zhu, Zhe; Zhang, Shineng.

Afiliación

Zhuan-Sun Y; Department of Respirology.
Huang F; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation.
Feng M; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation.
Zhao X; Department of Gastroenterology.
Chen W; Department of Nephrology.
Zhu Z; Department of Ultrasound, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China.
Zhang S; Department of Gastroenterology.

Onco Targets Ther ; 10: 5005-5012, 2017.

Article en En | MEDLINE | ID: mdl-29081663

Palabras clave

clinicopathologic characteristics; immune checkpoint; meta-analysis; pancreatic cancer; prognosis; programmed death-ligand 1

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Systematic_reviews Idioma: En Revista: Onco Targets Ther Año: 2017 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google